Turing Pharmaceuticals, under fire for raising the price of a drug used by cancer and AIDS patients by 5,000 percent, on Tuesday said it would offer its Daraprim medication to hospitals at what it called a "significant" price cut.
The Swiss company will slash the list price for Daraprim by as much as 50 percent and plans to make smaller bottles of the drug available starting next year to make it more affordable to stock. In addition, Turing will offer sample starter packages at no cost so physicians can start treatment immedi...
21:31 Time Warner jumps after hours on report it could sell for $110 per share to AT&T
14:38 Tesla buyers banned from ride-sharing with their vehicles1
11:10 Merged BAT-Reynolds could be loaded with up to $55 billion of debt, analysts say
11:25 Every Tesla car will contain the hardware to drive itself